Etoposide EP Impurity I
|
|
Etoposide EP Impurity I Eigenschaften
- Schmelzpunkt:
- 182-183 °C
- Siedepunkt:
- 773.9±60.0 °C(Predicted)
- Dichte
- 1.49±0.1 g/cm3(Predicted)
- pka
- 12.79±0.70(Predicted)
Sicherheit
Etoposide EP Impurity I Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Methoxy Etoposide is a derivative of Etoposide (E933750), a DNA topoisomerase II inhibitor. Etoposide is a semi-synthetic derivative of podophyllotoxin structurally related to Teniposide. Antineoplastic.Etoposide EP Impurity I Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Etoposide EP Impurity I Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 12)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Guangzhou CATO Research Chemicals Inc. | +86-020-81960175-617 +8615602392859 |
Intermediate@cato-chem.com | China | 5763 | 58 |
Moxin Chemicals | +8617320513646 |
mike@molcoo.com | China | 9563 | 58 |
Shenzhen SUNGENING Bio-Medical Co., Ltd. | 0755-28967200 13631290199 |
wxf@sungening.com | China | 9578 | 60 |
Jinan blalong chemical co. LTD | 2710913286@.com |
1513643261@qq.com | China | 14246 | 58 |
Shenzhen Jianyi Biotechnology Co., Ltd | 0755-84826604 |
3001783715@qq.com | CHINA | 2896 | 58 |
Changzhou Xianglong Pharmaceutical Technology Co., LTD | 0519-88910898 18661161657 |
yaoxiangqiu2021@163.com | China | 9996 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 0755-66853366; 13670046396 |
ORDERS@QCSRM.COM | China | 24342 | 58 |
Henan Vcommend Consultrading Co., Ltd. | 13393721940; 13393721940 |
sales@vcommend.com | China | 10005 | 58 |
ShenZhen H&D Pharmaceutical Technology Co., LTD | 2851922763 |
zhangweiyue@hdimpurity.com | China | 7879 | 58 |
Cato Research Chemicals Inc. | 13342851930 |
3008394369@qq.com | China | 15726 | 58 |
111712-42-6()Verwandte Suche:
Etoposid
1,3,3a,4,9,9a-Hexahydro-9-hydroxy-6,7-(methylendioxy)-4-(3',4',5'-trimethoxyphenyl)benz[f]isobenzofuran-3-on
- Etoposide EP Impurity I
- Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9S)-
- 111712-42-6